Ex post value reimbursement for pharmaceuticals

Medical Decision Making

Volumn 18, Issue 2 SUPPL., 1998, Pages

  Gravelle, Hugh S E ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Pharmaceuticals; Pharmacoeconomics; Price regulation; Public policy; Reimbursement

Indexed keywords

CLINICAL RESEARCH; DRUG COST; DRUG INDUSTRY; PHARMACOECONOMICS; REIMBURSEMENT; REVIEW;

DRUG INDUSTRY; ECONOMICS, PHARMACEUTICAL; PUBLIC POLICY; RESEARCH;

EID: 0031949333     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989x98018002s06     Document Type: Review

References (11)

1. Gravelle HSE. Ex post value regulation of pharmaceutical prices. In: Arestis P, Daniel S, Grahl J (eds). Regulation, Strategies and Policies: Essays in Microeconomics in Honour of Bernard Corry and Maurice Peston. London, U.K.: Edward Elgar, 1998.
2. Bloor K, Maynard A, Freemantle N. Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industry. BMJ. 1996;313:33-5.
3. Loeb M, Magat WA. A decentralized method for utility regulation. Journal of Law and Economics. 1979;22:399-404.
4. Kremer M. A mechanism for encouraging innovation. Harvard Institute for International Development Discussion Paper, no. 533, May 1996.
5. Laffont JJ, Tirole J. A Theory of Incentives in Procurement and Regulation, Cambridge, MA: MIT Press, 1993.
6. Arrow KJ. Uncertainty and the welfare economics of medical care. American Economic Review. 1963;53:941-73.
7. Drummond M, et al. Economic evaluation of pharmaceuticals: a European perspective. Pharmo-Economics. 1993;4:173-86.
8. Drummond M, Jönsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy. 1997;40:199-215.
9. Vickrey W. Automobile accidents, tort law, externalities and insurance. Journal of Law and Contemporary Problems. 1968;33:464-87.
10. Earl-Slater A. Regulating the price of the UK's drugs. BMJ. 1997;314:365-8.
11. Towse A (ed). Guidelines for the Economic Evaluation of Pharmaceuticals: What Can the UK Learn from Australia and Canada? London, U.K.: Office of Health Economics, 1997.